Login to Your Account


To deal with oncology therapy resistance, play chess, not tennis

By Anette Breindl
Science Editor

Monday, April 21, 2014

When cancers become resistant to the drugs used to treat them, it has become possible – at least in principle – to understand the cause of that resistance through sequencing, and if a drug exists that is effective against cells with the mutation, to change a patient's treatment accordingly. But a better strategy might be to prevent resistance from developing at all.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription